BioSpace News Archive

New research published in BMJ Open outlines findings from a study on multiorgan impairment in individuals with persistent symptoms following recovery from COVID-19 infection— a condition referred to as long COVID.

Halberd Corporation filed an International Patent Cooperation Treaty application for coverage of the invention titled, “Treating and Curing Covid-19 Infection Utilizing a Laser.” The Patent Cooperation Treaty has over 150 participating countries and allows an inventor to seek patent protection in numerous countries simultaneously.

LUNGevity Foundation, the nation’s leading lung cancer-focused nonprofit organization, is pleased to announce the hiring of Kristi M. Griffith, MSN, RN, CHPN, HON ONN-CG, as a survivorship navigator.

Rare Disease Diversity Coalition Observes National Minority Health Month; Continue Work to Advance Racial Health Equity Informed by Experts

Transaction to Strengthen Regional Presence in the Companion Veterinary Market

Antares Pharma, Inc. (NASDAQ: ATRS) (“the Company”), a specialty pharmaceutical company, today announced the appointment of Peter Richardson, MRCP, as Executive Vice President, Research and Development and Chief Medical Officer.

Applied DNA Sciences, Inc. (NASDAQ: APDN) (“Applied DNA” or the “Company”), a leader in Polymerase Chain Reaction (PCR)-based DNA manufacturing, today announced that it secured an amendment to a Master Services Agreement (MSA) with an existing customer of its Linea™ COVID-19 Assay Kit (the “Assay Kit”).

TrustGrid Pty Ltd., creators of the world’s first digital trust ecosystem, today announced a new use case for its platform to provide citizens with a secure digital vaccine passport that can be stored on their smartphone

INmune Bio, Inc. (NASDAQ: INMB) (the “Company” or “INmune”), a clinical-stage immunology company focused on developing treatments that harness a patient’s innate immune system to fight disease, today announced that Raymond J. Tesi, MD, President and CEO, will participate in a fireside chat at the B Riley Neuroscience Conference on Wednesday, April 28.

Core One Labs Inc., is pleased to announce its wholly owned subsidiary Vocan, has entered into a Collaborative Research Agreement with the University of British Columbia.